Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines

BACKGROUND: YM529 is a newly developed nitrogen-containing bisphosphonate (BP) classified as a third-generation BP that shows a 100-fold greater potency against bone resorption than pamidronate, a second-generation BP. This agent is, therefore expected to be extremely useful clinically for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshimune, Ryuichiro, Aoe, Motoi, Toyooka, Shinichi, Hara, Fumikata, Ouchida, Mamoru, Tokumo, Masaki, Sano, Yoshifumi, Date, Hiroshi, Shimizu, Nobuyoshi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781945/
https://www.ncbi.nlm.nih.gov/pubmed/17222343
http://dx.doi.org/10.1186/1471-2407-7-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781945/
https://www.ncbi.nlm.nih.gov/pubmed/17222343
http://dx.doi.org/10.1186/1471-2407-7-8

Ejemplares similares